Lv1
16 积分 2023-11-30 加入
Drugs as CYP3A Probes, Inducers, and Inhibitors
7天前
已完结
Drug metabolic stability in early drug discovery to develop potential lead compounds
15天前
已完结
Strategies and Recommendations for Using a Data‐Driven and Risk‐Based Approach in the Selection of First‐in‐Human Starting Dose: An International Consortium for Innovation and Quality in Pharmaceutical Development (IQ) Assessment
19天前
已完结
Abstract 4088: First-in-human dose selection for ALKS 4230, an investigational immunotherapeutic agent
19天前
已完结
Discovery and Optimization of Potent, Selective, and Brain-Penetrant 1-Heteroaryl-1H-Indazole LRRK2 Kinase Inhibitors for the Treatment of Parkinson’s Disease
1个月前
已完结
Discovery of the Potent and Selective Inhaled Janus Kinase 1 Inhibitor AZD4604 and Its Preclinical Characterization
1个月前
已完结
Discovery of the Potent and Selective Inhaled Janus Kinase 1 Inhibitor AZD4604 and Its Preclinical Characterization
1个月前
已完结
Discovery of BMS-986308: A Renal Outer Medullary Potassium Channel Inhibitor for the Treatment of Heart Failure
1个月前
已完结
Biochemical mechanisms of drug action: what does it take for success?
3个月前
已完结
In vivo Target Residence Time and Kinetic Selectivity: The Association Rate Constant as Determinant
3个月前
已完结
皖公网安备34019202002308
